9,312
Total Claims
$1.9M
Drug Cost
532
Beneficiaries
$3,594
Cost/Patient
Peer Comparison vs. 110,156 Internal Medicine providers
-92%
Opioid rate vs peers
0.2% vs 2.2% avg
+155%
Cost per patient vs peers
$3,594 vs $1,411 avg
+48%
Brand preference vs peers
15.8% vs 10.6% avg
Opioid Prescribing
0.2%
Opioid Rate
16
Opioid Claims
$142
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
84% generic
Brand: 1,442 claims · $1.8M
Generic: 7,712 claims · $133K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dapagliflozin Propanediol | 87 | $133K |
| Leuprolide Acetate | 17 | $119K |
| Linagliptin | 67 | $102K |
| Fluticasone/Umeclidin/Vilanter | 77 | $99K |
| Empaglifloz/Linaglip/Metformin | 57 | $90K |
| Empagliflozin/Linagliptin | 47 | $82K |
| Darunavir/Cob/Emtri/Tenof Alaf | 17 | $82K |
| Apixaban | 66 | $80K |
| Sitagliptin Phosphate | 60 | $79K |
| Sacubitril/Valsartan | 37 | $68K |
| Dolutegravir Sodium | 28 | $63K |
| Dulaglutide | 41 | $55K |
| Bictegrav/Emtricit/Tenofov Ala | 13 | $54K |
| Emtricitabine/Tenofov Alafenam | 22 | $51K |
| Rivaroxaban | 29 | $41K |
Prescribing Profile
Patient Profile
73
Avg Age
53%
Female
1.32
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data